| |
| |
|
| Insider
Information: |
Kakkis Emil D |
| Relationship: |
|
| City: |
Novato |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
603,534 |
|
|
Indirect Shares
|
2,268,639 |
|
|
| Direct
Value |
$27,618,890 |
|
|
|
Indirect Value
|
$97,197,843 |
|
|
| Total
Shares |
2,872,173 |
|
|
| Total
Value |
$124,816,733 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biomarin Pharmaceutical Inc |
BMRN |
Chief Medical Officer |
2009-03-02 |
39,621 |
2009-03-02 |
4,654 |
Premium* |
|
|
Ultragenyx Pharmaceutical Inc |
RARE |
|
2024-03-01 |
563,913 |
2024-03-01 |
2,263,985 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
106 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Business Operations |
• – – |
2003-12-29 |
4 |
OE |
$7.00 |
$71,309 |
I/I |
10,187 |
21,297 |
|
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Business Operations |
• – – |
2003-12-29 |
4 |
AS |
$7.57 |
$77,120 |
I/I |
(10,187) |
11,110 |
|
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Business Operations |
• – – |
2004-05-06 |
4 |
B |
$6.48 |
$97,400 |
I/I |
15,000 |
26,110 |
1.99 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Business Operations |
• – – |
2004-10-31 |
4 |
A |
$3.51 |
$6,754 |
D/D |
1,924 |
25,034 |
|
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Business Operations |
• – – |
2005-05-02 |
4 |
A |
$3.43 |
$6,758 |
D/D |
1,968 |
27,002 |
|
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
officerTitle |
• – – |
2005-10-31 |
4 |
A |
$3.43 |
$8,832 |
D/D |
2,572 |
29,574 |
|
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
• – – |
2006-01-04 |
4 |
OE |
$4.00 |
$200,000 |
D/D |
50,000 |
88,144 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
• – – |
2006-04-28 |
4 |
A |
$3.43 |
$14,430 |
D/D |
4,202 |
33,776 |
|
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
• – – |
2006-10-31 |
4 |
B |
$3.43 |
$15,000 |
D/D |
4,368 |
38,144 |
2.74 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
• – – |
2007-04-30 |
4 |
B |
$5.19 |
$15,462 |
D/D |
2,982 |
94,126 |
2.74 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
• – – |
2007-10-31 |
4 |
B |
$6.92 |
$14,101 |
D/D |
2,038 |
96,164 |
2.74 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
• – – |
2007-12-17 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,000 |
86,164 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
• – – |
2008-03-06 |
4 |
AS |
$37.99 |
$686,870 |
D/D |
(18,000) |
86,164 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
• – – |
2008-03-06 |
4 |
OE |
$4.00 |
$72,000 |
D/D |
18,000 |
104,164 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
• – – |
2008-04-01 |
4 |
AS |
$35.71 |
$353,835 |
D/D |
(9,857) |
86,164 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
• – – |
2008-04-01 |
4 |
OE |
$4.00 |
$72,000 |
D/D |
18,000 |
104,164 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
• – – |
2008-04-01 |
4 |
AS |
$35.65 |
$291,120 |
D/D |
(8,143) |
96,021 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
• – – |
2008-04-29 |
4 |
OE |
$4.00 |
$300,000 |
D/D |
75,000 |
161,164 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
• – – |
2008-04-30 |
4 |
AB |
$10.37 |
$17,007 |
D/D |
1,640 |
162,804 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
• – – |
2008-05-01 |
4 |
OE |
$4.00 |
$72,000 |
D/D |
18,000 |
180,804 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
• – – |
2008-05-01 |
4 |
AS |
$37.31 |
$674,857 |
D/D |
(18,000) |
162,804 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
• – – |
2008-06-02 |
4 |
OE |
$4.00 |
$64,000 |
D/D |
16,000 |
178,804 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
• – – |
2008-06-02 |
4 |
AS |
$37.57 |
$677,367 |
D/D |
(18,000) |
160,804 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
• – – |
2008-07-07 |
4 |
AS |
$27.90 |
$505,076 |
D/D |
(18,000) |
145,304 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
• – – |
2008-07-07 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
163,304 |
0 |
- |
|
106 Records found
|
|
Page 1 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
